TRPV2 Assay Using Cannabinoid Agonists and Temperature Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack a systematic approach for screening, identifying, and characterizing modulators of TRPV2, particularly due to the lack of selective TRPV2 agonists and technical difficulties in assaying these channels in high temperature environments.
Innovation Solution
The use of cannabinoids, specifically Δ9-THC, to activate TRPV2 channels, with methods involving contacting TRPV2 polypeptides with cannabinoids, measuring biological activity, and designing structural analogs to increase or decrease TRPV2 activity, allowing for the identification of compounds that modulate TRPV2 activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional screening methods are used for TRPV2 modulators, then the process is simpler, but no selective TRPV2 agonists can be identified and the assay fails in high temperature environments
Solution Approach 1:
The patent uses an intermediary substance (a selective TRPV2 agonist) to mediate the detection of TRPV2 channel activity. This intermediary enables specific activation of TRPV2 channels, allowing reliable differentiation between TRPV2 and other TRP channels (such as TRPV1) that may be co-expressed in the assay system, thereby resolving the reliability issue in high temperature environments
Solution Approach 2:
The patent employs parameter changes by utilizing temperature as a critical assay parameter. By conducting assays at temperatures above 42°C (specifically 43-50°C), the method selectively activates TRPV2 channels while avoiding activation of TRPV1 channels, which have lower thermal thresholds. This parameter change enables reliable TRPV2-specific detection despite the complexity of the screening system
2Productivity
If high temperature assay conditions are used to activate TRPV2, then TRPV2 channel activity increases, but technical difficulties arise in maintaining stable assay conditions
Solution Approach 1:
The patent applies preliminary action by pre-warming the assay buffer and all reagents to the target temperature (43-50°C) before initiating the assay. This preliminary temperature equilibration prevents thermal shock to the cells and ensures stable baseline conditions, thereby maintaining assay reliability while achieving effective TRPV2 activation
Solution Approach 2:
The patent uses a controlled temperature copying approach by maintaining the assay environment at a consistent elevated temperature throughout the experiment. This includes using temperature-controlled incubators, heated stage microscopes, and pre-warmed imaging buffers, which copy and maintain the optimal temperature conditions for TRPV2 activation, ensuring both high productivity and assay stability
3Measurement precision
If selective TRPV2 agonists are developed, then TRPV2 modulator identification becomes more accurate, but the lack of known selective agonists currently prevents this
Solution Approach 1:
The patent applies self-service by using the TRPV2 channel itself to identify selective agonists. The method screens compound libraries for substances that activate TRPV2 channels under high temperature conditions (43-50°C), where TRPV2 is selectively activated while TRPV1 remains inactive. This self-service approach allows the system to generate its own reference data for selective TRPV2 agonists without relying on pre-existing knowledge
Solution Approach 2:
The patent implements feedback by using the temperature-dependent activation pattern as a selection criterion. Compounds that activate TRPV2 are identified by their ability to produce channel activity specifically at elevated temperatures (43-50°C) but not at lower temperatures (below 42°C). This feedback mechanism based on temperature-responsive activity patterns enables accurate measurement of TRPV2-specific effects and builds a reference database of selective agonists
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the effective stimulation of noxious thermo-sensation and provides a method for identifying compounds that increase or decrease TRPV2 biological activity, potentially leading to therapeutic applications for pain management.
Implementation Method 1
TRPV2, also termed VRL-1, has been proposed as a sensor of noxious temperatures (>52° C.), which presumably mediates 'first' pain
Implementation Method 2
When these stimuli are in the noxious range (i.e., very hot or cold), they activate a certain subset of thermal receptors on a sub-population of sensory neurons called nociceptors (pain-sensing neurons). Upon activation, the thermal receptors (e.g., ion channels) transduce the noxious stimulus into an electrical signal
Data Source
AI summary
It has now been discovered that certain cannabinoids specifically activate TRPV2 channel activity. Based on the discovery, novel compositions and methods for screening, identifying and characterizing compounds that increase or decrease the biological activity of a TRPV2.